AORT(Artivion, Inc.) · 财务报表

AORT(Artivion, Inc.) 的财务报表:医疗保健,医疗器械。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$298.84M$313.79M$354.00M$388.54M$441.33M
毛利润$197.51M$202.52M$229.18M$248.78M$284.23M
营业利润$8.12M$6.20M$5.74M$38.87M$33.74M
净利润−$14.83M−$19.19M−$30.69M−$13.36M$9.77M
经营现金流−$2.58M−$5.15M$18.82M$22.24M$39.88M
自由现金流−$15.68M−$15.87M$9.07M$11.05M$839.00K
摊薄每股收益$-0.38$-0.48$-0.75$-0.32$0.21

Artivion, Inc. AORT